Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and nuclear markets, today announces that, following conclusion of a fixed-term contract, Cantor Fitzgerald Europe have completed their tenure as the Company's joint broker. Cenkos Securities plc will continue to act as the Company's nominated adviser and sole broker.
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO Derek Bulmer, CFO
+44 (0)1740 626 060
Cenkos Securities plc
Max Hartley (NOMAD) Julian Morse (Sales)
+44 (0)20 7397 8900
Luther Pendragon Ltd
Harry Chathli Claire Norbury Alexis Gore
+44 (0)20 7618 9100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Proactive Investors speaks to Sir Peter Williams, science and engineering veteran and newly appointed chairman of Kromek (LON:KMK).
Williams, who has also been chairman and chief executive of Oxford Instruments (LON:OXIG), says he hopes to sharpen the commercial and strategic focus of the...